J1A2 T cells were able to mediate in vitro cytotoxicity against HLA-A*02:01+ and CD20+ mantle cell lymphoma cell line (JVM2) and Hodgkin lymphoma cell line (RPMI6666) (Fig. 2D). The gene discussed is HLA-A; the disease is Hodgkins lymphoma.